ARADIGM CORP. ARDM Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ARADIGM CORP. ARDM

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (123)	12/18/2001 4:24:28 PM
From: rkrw	Read Replies (2) of 255

Tuck, what makes you think I'm an "expert"?! Message 16806252 One thing I'm not is an expert. I can try to answer your questions as they relate to todays inhl/pfe news. The pulmonary side effect issues are different than the antibody issue and likely of much greater relevance. I guess this is borne out in pfe's updated and fda driven plans. Todays exubera update was known and expected for a long time. That anyone is surprised is surprising. I nearly shorted inhl this morning at $20 as I was surprised the stock was moving up in front of any pfe revelations. As this relates to ardm, the good news is, clinically there is no doubt that inhaled insulin works. The bad news, does exubera make the aerx clinical path more difficult and lengthy? Are the problems exubera has encountered specific to their product formulation? Will aerx see similar pulmonary side effects? Will any inhaled insulin be able to pass fda scrutiny?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next